A review of the impact of hormone therapy on prefrontal structure and function at menopause

References

• World Health Organization. Research on the menopause in the 1990s: report of a WHO scientific group. Geneva (Switzerland): World Health Organization; 1996.
   Google Scholar
• Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14:199–215.
   PubMed Web of Science ®Google Scholar
• Sussman M, Trocio J, Best C, et al. Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records. BMC Women’s Health. 2015;15:1–5.
   PubMed Web of Science ®Google Scholar
• Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118:14–24.
   PubMed Web of Science ®Google Scholar
• Rosano G, Vitale C, Marazzi G, et al. Menopause and cardiovascular disease: the evidence. Climacteric. 2007;10:19–24.
   PubMed Web of Science ®Google Scholar
• Atsma F, Bartelink M-LE, Grobbee DE, et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265–279.
   PubMed Web of Science ®Google Scholar
• Muka T, Oliver-Williams C, Colpani V, et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PloS One. 2016;11:e0157417.
   PubMed Web of Science ®Google Scholar
• Greendale GA, Karlamangla AS, Maki PM. The menopause transition and cognition. JAMA. 2020;323:1495–1496.
   PubMed Web of Science ®Google Scholar
• Pertesi S, Coughlan G, Puthusseryppady V, et al. Menopause, cognition and dementia – a review. Post Reprod Health. 2019;25:200–206.
   PubMedGoogle Scholar
• Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2014;142:90–98.
   PubMed Web of Science ®Google Scholar
• Maki PM, Henderson VW. Cognition and the menopause transition. Menopause. 2016;23:803–805.
   PubMed Web of Science ®Google Scholar
• O’Neill S, Eden J. The pathophysiology of menopausal symptoms. Obstet Gynaecol Reprod Med. 2012;22:63–69.
   Google Scholar
• de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Maturitas. 2016;91:153–155.
   PubMed Web of Science ®Google Scholar
• De Villiers T, Gass M, Haines C, et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013;16:203–204.
   PubMed Web of Science ®Google Scholar
• Hogervorst E. Estrogen and the brain: does estrogen treatment improve cognitive function? Menopause Int. 2013;19:6–19.
   PubMedGoogle Scholar
• Gava G, Orsili I, Alvisi S, et al. Cognition, mood and sleep in menopausal transition: the role of menopause hormone therapy. Medicina. 2019;55:668.
   Web of Science ®Google Scholar
• Fait T. Menopause hormone therapy: latest developments and clinical practice. Drugs Context. 2019;8:212551.
   PubMedGoogle Scholar
• Pinkerton JV, Stovall DW. Reproductive aging, menopause, and health outcomes. Ann N Y Acad Sci. 2010;1204:169–178.
   PubMed Web of Science ®Google Scholar
• Pinkerton JV, Stovall DW, Kightlinger RS. Advances in the treatment of menopausal symptoms. Womens Health (Lond). 2009;5:361–384.
   PubMedGoogle Scholar
• Yoon B-K, Chin J, Kim J-W, et al. Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial. Menopause. 2018;25:870–876.
   PubMed Web of Science ®Google Scholar
• Duka T, Tasker R, McGowan J. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl). 2000;149:129–39.
   PubMed Web of Science ®Google Scholar
• Koebele SV, Mennenga SE, Hiroi R, et al. Cognitive changes across the menopause transition: a longitudinal evaluation of the impact of age and ovarian status on spatial memory. Horm Behav. 2017;87:96–114.
   PubMed Web of Science ®Google Scholar
• Mueller S, Grissom E, Dohanich G. Assessing gonadal hormone contributions to affective psychopathologies across humans and animal models. Psychoneuroendocrinology. 2014;46:114–128.
   PubMed Web of Science ®Google Scholar
• Henderson VW, Greicius MD. Functional magnetic resonance imaging and estrogen effects on the brain: cautious interpretation of a BOLD finding. Menopause. 2010;17:669–671.
   PubMed Web of Science ®Google Scholar
• Bayer U, Hausmann M. Sex hormone therapy and functional brain plasticity in postmenopausal women. Neuroscience. 2011;191:118–128.
   PubMed Web of Science ®Google Scholar
• Beltz AM, Moser JS. Ovarian hormones: a long overlooked but critical contributor to cognitive brain structures and function. Ann N Y Acad Sci. 2020;1464:156–180.
   PubMed Web of Science ®Google Scholar
• Comasco E, Frokjaer VG. Sundström-Poromaa I. Functional and molecular neuroimaging of menopause and hormone replacement therapy. Frontiers Neurosci. 2014;8:388
   PubMed Web of Science ®Google Scholar
• File SE, Hartley DE, Elsabagh S, et al. Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause. 2005;12:193–201.
   PubMed Web of Science ®Google Scholar
• Hogervorst E, Williams J, Budge M, et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101:485–512.
   PubMed Web of Science ®Google Scholar
• Krug R, Born J, Rasch B. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women. Psychoneuroendocrinology. 2006;31:965–975.
   PubMed Web of Science ®Google Scholar
• Carlén M. What constitutes the prefrontal cortex? Science. 2017;358:478–482.
   PubMed Web of Science ®Google Scholar
• Wilson CR, Gaffan D, Browning PG, et al. Functional localization within the prefrontal cortex: Missing the forest for the trees? Trends Neurosci. 2010;33:533–540.
   PubMed Web of Science ®Google Scholar
• Brase GL, Raffone A. The key role of prefrontal cortex structure and function. Behav Brain Sci. 2006;29:22.
   Web of Science ®Google Scholar
• Petrides M, Tomaiuolo F, Yeterian EH, et al. The prefrontal cortex: comparative architectonic organization in the human and the macaque monkey brains. Cortex. 2012;48:46–57.
   PubMed Web of Science ®Google Scholar
• Erickson KI, Colcombe SJ, Raz N, et al. Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol Aging. 2005;26:1205–1213.
   PubMed Web of Science ®Google Scholar
• Maki PM. The critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause. 2013;20:695–709.
   PubMed Web of Science ®Google Scholar
• Lord C, Engert V, Lupien SJ, et al. Effect of sex and estrogen therapy on the aging brain: a voxel-based morphometry study. Menopause. 2010;17:846–851.
   PubMed Web of Science ®Google Scholar
• Boccardi M, Ghidoni R, Govoni S, et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study. Menopause. 2006;13:584–591.
   PubMed Web of Science ®Google Scholar
• Coker LH, Espeland MA, Hogan PE, et al. Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies. Neurology. 2014;82:427–434.
   PubMed Web of Science ®Google Scholar
• Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology. 2009;72:135–142.
   PubMed Web of Science ®Google Scholar
• Zhang T, Casanova R, Resnick SM, et al. Effects of hormone therapy on brain volumes changes of postmenopausal women revealed by optimally-discriminative voxel-based morphometry. PloS One. 2016;11:e0150834–e0150834.
   Web of Science ®Google Scholar
• Kim GW, Park K, Jeong GW. Effects of sex hormones and age on brain volume in post-menopausal women. J Sex Med. 2018;15:662–670.
   PubMed Web of Science ®Google Scholar
• Erickson KI, Colcombe SJ, Elavsky S, et al. Interactive effects of fitness and hormone treatment on brain health in postmenopausal women. Neurobiol Aging. 2007;28:179–185.
   PubMed Web of Science ®Google Scholar
• Kantarci K, Tosakulwong N, Lesnick TG, et al. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology. 2018;90:e1404–e1412.
   PubMed Web of Science ®Google Scholar
• Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA. 1999;281:1197–1202.
   PubMed Web of Science ®Google Scholar
• Epperson CN, Amin Z, Ruparel K, et al. Interactive effects of estrogen and serotonin on brain activation during working memory and affective processing in menopausal women. Psychoneuroendocrinology. 2012;37:372–382.
   PubMed Web of Science ®Google Scholar
• Berent-Spillson A, Briceno E, Pinsky A, et al. Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology. 2015;59:25–36.
   PubMed Web of Science ®Google Scholar
• Berent-Spillson A, Persad CC, Love T, et al. Early menopausal hormone use influences brain regions used for visual working memory. Menopause. 2010;17:692.
   PubMed Web of Science ®Google Scholar
• Joffe H, Hall JE, Gruber S, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause. 2006;13:411–422.
   PubMed Web of Science ®Google Scholar
• Smith YR, Love T, Persad CC, et al. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J Clin Endocrinol Metab. 2006;91:4476–4481.
   PubMed Web of Science ®Google Scholar
• Dumas JA, Kutz AM, Naylor MR, et al. Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women. Neuroimage. 2012;60:1394–1403.
   PubMed Web of Science ®Google Scholar
• Persad CC, Zubieta J-K, Love T, et al. Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy. Fertil Steril. 2009;92:197–204.
   PubMed Web of Science ®Google Scholar
• Love T, Smith YR, Persad CC, et al. Short-term hormone treatment modulates emotion response circuitry in postmenopausal women. Fertil Steril. 2010;93:1929–1937.
   PubMed Web of Science ®Google Scholar
• Shafir T, Love T, Berent-Spillson A, et al. Postmenopausal hormone use impact on emotion processing circuitry. Behav Brain Res. 2012;226:147–153.
   PubMed Web of Science ®Google Scholar
• Archer JS, Love-Geffen TE, Herbst-Damm KL, et al. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women. Menopause. 2006;13:528–537.
   PubMed Web of Science ®Google Scholar
• Stevens MC, Clark VP, Prestwood KM. Low-dose estradiol alters brain activity. Psychiatry Res. 2005;139:199–217.
   PubMed Web of Science ®Google Scholar
• Berent-Spillson A, Kelley AS, Persad CC, et al. Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function. Menopause. 2018;25:1424.
   PubMed Web of Science ®Google Scholar
• Girard R, Météreau E, Thomas J, et al. Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity. Sci Reports. 2017;7:11.
   PubMed Web of Science ®Google Scholar
• Thomas J, Météreau E, Déchaud H, et al. Hormonal treatment increases the response of the reward system at the menopause transition: a counterbalanced randomized placebo-controlled fMRI study. Psychoneuroendocrinology. 2014;50:167–180.
   PubMed Web of Science ®Google Scholar